DOI : 10.1055/s-00000036

Laryngo-Rhino-Otologie

Issue S 02 · Volume 101 · May 2022 DOI: 10.1055/s-012-53666


Abstract- und Posterband - 93. Jahresversammlung der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Hals-Chirurgie e.V., Bonn Interface - Fokus Mensch im Zeitalter der technisierten Medizin
Deutsche Messe Hannover, 25.–28.05.2022

Prof. Dr. med. Dr. med. dent. Hans-J. Welkoborsky

Althaus, Laurenz; Tamaskovics, Balint; Scheckenbach, Kathrin; Plettenberg, Christian: Quality analysis on real-life-data for immunotherapy in head and neck cancer: pembrolizumab vs. nivolumab
Brand, Matthias; von Witzleben, Adrian; Vahl, Julius; Döscher, Johannes; Theodoraki, Marie-Nicole; Hoffmann, Thomas K.; Laban, Simon: Immune-mediated adverse events and their clinical management in head and neck cancer patients under anti-PD-1/PD-L1 immunotherapy
Leffers, David; Idel, Christian; Bruchhage, Karl-Ludwig: Complete response under pembrolizumab therapy
Schnatmann, Jana; Bochen, Florian; Körner, Sandrina; Kühn, Jan Philipp; Schick, Bernhard; Linxweiler, Maximilian: Proliferation and migration inhibitory effect of calcitriol on head and neck cancer cells – a new therapeutic approach for the treatment of head and neck tumor patients?
Seiz, Elena; Azhakesan, Alexya; Ludwig, Sonja; Ittensohn, Julia; Huber, Lena; Bieback, Karen; Kern, Johann; Rotter, Nicole; Affolter, Annette: Use of xeno-free serum substitutes in ex vivo HNSCC tissue cultures to predict the therapy response
von Fournier, Armin; Gehrke, Thomas; Ehret, Kasemo Totta; Hagen, Rudolf; Scherzad, Agmal: Does cisplatin affect the differentiation of mesenchymal stem cells?